Ascendis Health Limited provides earnings guidance for the full year ended June 2023. For the year, company expects earnings per share will be between 11.2 cents and 13.7 cents, representing a decrease of between 88.1% and 85.4% compared to the restated earnings per share from total operations of 93.6 cents reported for the prior corresponding period; and headline loss per share will be between 35.7 cents and 43.6 cents, representing an improvement of between 55.8% and 46.0% compared to the restated headline loss per share from total operations of 80.8 cents reported for the prior corresponding period.